Tempus AI received a 510(k) Premarket Notification from the FDA to indicate that the Tempus ECG-AF device was judged “Substantially Equivalent,” according to a notice posted to the FDA site with a decision date of June 21.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
Questions or Comments about the article? Write to editor@tipranks.com